glp-1/gip/gcg receptor agonist Neurotrophic and neuroprotective effects of a monomeric triagonist in cellular and rodent models of mild traumatic brain injury GLP-1 & GIP Agonists |
Description
But theres a tradeoff
This drug candidate has an interesting proposed mechani...
Obesity management: Used widely for weight loss, even in non-diabetic individuals
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are emerging glucose-lowering agents primarily used in managing diabetes and obesity
Background Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus (T2DM)
